Antibiotic drug research and development

BMJ 2012; 344 doi: http://dx.doi.org/10.1136/bmj.e2591 (Published 11 April 2012)
Cite this as: BMJ 2012;344:e2591

Related articles

Letter: Existing classes of antibiotics are probably the best we will ever have

Editor's Choice: Back to basics with the three Rs

Analysis: Challenges of drug resistance in the developing world

Analysis: 3Rs for innovating novel antibiotics: sharing resources, risks, and rewards

See more

Feature: Cancer Care Team

Editorial: The safety of incretin based drugs

Practice: Should doctors prescribe cannabinoids?

Endgames: Treatment allocation in trials: cluster randomisation

This article has been cited by other articles:

THIS WEEK'S POLL